Back to Explorer

Guidance for the Content of Premarket Notifications for Conventional and Antimicrobial Foley Catheters

FinalCenter for Devices and Radiological Health09/11/1994

Description

This guidance was written prior to the February 27, 1997 implementation of FDA’s Good Guidance Practices, GGP’s. It does not create or confer rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both. This guidance will be updated in the next revision to include the standard elements of GGP’s.

Scope & Applicability

Product Classes

4
Electronic Thermometers

software controlled electronic thermometers requiring level of concern indication

Conventional and Antimicrobial Foley Catheters

Guidance for the Content of Premarket Notifications for Conventional and Antimicrobial Foley Catheters

Clinical Electronic Thermometer

A device used to measure the body temperature of a patient by means of a transducer

Class II

The devices that are the subject of this guidance are Class II non-spinal metallic bone screws and washers

Stakeholders

4
manufacturer

Entity required to conduct postmarket surveillance; entity responsible for submitting postmarket surveillance plans; Entity holding the approved PMA, HDE, or cleared 510(k); The entity responsible for conducting postmarket surveillance and submitting reports.; Entity that can use the checklist as a reference for submissions.

importer

Person responsible for establishing FSVP; Person in the United States who owns or has purchased the food at time of entry; entity responsible for FSVP compliance; Entity responsible for FSVP compliance; Entity responsible for conducting hazard analysis; Subject of FSVP requirements for food for humans and animals.; The entity responsible for FSVP compliance and supplier approval.; entity responsible for foreign supplier verification; entity responsible for developing FSVP; entity responsible for

distributor

Entity involved in investigational drug supply chain

applicant

entity submitting marketing applications

Regulatory Context

Attributes

5
Accuracy

Performance characteristic assessed via linearity experiment

radiation dose

mathematical equations used to derive the estimates

Intended Use

Evidence of a new intended use based on communications

Level of Concern

Categorization (minor, moderate, major) for software risk.

Precision

Closeness of agreement between a series of measurements from multiple samplings.; Performance characteristic measured by intermediate precision; Performance characteristic to be validated

Related CFR Sections (5)

Related Warning Letters (2)

  • Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)

    WHOOP, Inc.

    2025-07-15
  • CGMP/QSR/Medical Devices/Misbranded

    Wello Inc.

    2023-11-14

See Also (8)

Guidance for the Content of Premarket Notifications for Conventional and Antimicrobial Foley Catheters | Guideline Explorer | BioRegHub